Business Development

We are committed to strategic growth through targeted product acquisition.  The company actively pursues product/program purchase, in-licensing, and co-development opportunities that are aligned with its internal areas of expertise and offer significant value to its pipeline.

 

Please direct Business Development inquiries to:

Hari Miskin
TG Therapeutics, Inc.
787 Seventh Avenue
48th Floor
New York, NY  10019
212.554.4484 (phone)
212.554.4531 (fax)
information@tgtxinc.com